All News

 
News – PrimeVigilance Latest Webinar ‘A Human Touch: Real-World Patient Data in Regulatory Submissions and Beyond’

PrimeVigilance proudly present our latest webinar
‘A Human Touch: Real-World Patient Data in Regulatory Submissions and Beyond’, hosted alongside Pharmafocus and features speakers Dr Forstner, Senior VP and Head of Pharmacoepidemiology and Risk Management and Maartje Smulders, Senior Director Pharmacoepidemiology.

Published
15 February 2019.

Read more
 
News – Dr. Michael Forstner invited to teach at the DIA Europe Annual Meeting in Vienna

PrimeVigilance expert in Benefit-Risk Management, Dr. Michael Forstner PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology invited to teach at the upcoming DIA Europe Annual Meeting in Vienna, taking place on 4-7 February 2019.

Published
18 January 2019.

Read more
 
News – Dr. Michael Forstner & Dr. Jan Petracek selected to speak at DIA Pharmacovigilance & Risk Management Strategies Conference

PrimeVigilance is pleased to announce that both Dr. Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr. Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA PVRMS conference held January 28-30 in Washington, DC.

Published
13 December 2018.

Read more
 
News – Ergomed shortlisted for Best Technological Development in Clinical Trials at SCRIP Awards 2018

London, UK – 28 November 2018: Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, is delighted to have been shortlisted for the Best Technological Development in Clinical Trials category at the 14th Annual SCRIP Awards

Published
28 November 2018.

Read more
 
NEWS – PrimeVigilance becomes a global leader in QPPV services

Guildford, UK – 24th October 2018

PrimeVigilance have become WORLDWIDE NUMBER ONE in QPPV services with 25 EU QPPV assignments, as well as 25 Deputy EU QPPVs, and our local QPPV/NPRP network covering over 60 countries !

Published
24 October 2018.

Read more
 
NEWS – Dr Jan Petracek Lecturing at the MHRA/DIA Excellence in Pharmacovigilance Course in London, Oct 15 – 19, 2018

We are pleased to share the news that Dr Jan Petracek, PrimeVigilance CEO and a leading expert in Pharmacovigilance, will be lecturing at the upcoming MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing course held in London on Oct 15 – 19, 2018.

Published
14 September 2018.

Read more